Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath

Rambam Health Care Campus

Status: Completed

Conditions: Parkinson's Disease; Parkinsonism

Treatments: Other: collection of exhaled breath

Study type: Observational

Funder types: Other

Identifiers

NCT01246336

RMB09-0196

Details and patient eligibility

About

Parkinson's disease is diagnosed clinically, because biomarkers that may help in diagnosis and differential diagnosis are not yet available. Exhaled breath testing may yield a "breath-print" that can be used to distinguish healthy and diseased states.

Enrollment: 41 patients

Sex: All

Ages: 30+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients with Parkinsonism

Exclusion criteria

• Severe dementia

Trial design

41 participants in 2 patient groups

Patients with parkinsonism

Description:

Patients suffering from Parkinson's disease or parkinsonism

Treatment:

Other: collection of exhaled breath

Healthy controls

Description:

Patients not suffering from Parkinson's disease or any other neurological disorder

Treatment:

Other: collection of exhaled breath